Introduction:
The global market for rotavirus vaccines is steadily growing, with a particular focus on Brazil in 2026. In recent years, the demand for rotavirus vaccines has been increasing due to the rising awareness about the importance of vaccination in preventing rotavirus infections. According to recent statistics, the global market for rotavirus vaccines is expected to reach $1.2 billion by 2026.
Top 10 Rotavirus Vaccine Producers in Brazil 2026:
1. Butantan Institute:
– Production volume: 5 million doses per year
– The Butantan Institute is a leading producer of rotavirus vaccines in Brazil, known for its high-quality and affordable vaccines.
2. Fiocruz:
– Market share: 30%
– Fiocruz is a key player in the rotavirus vaccine market in Brazil, with a significant market share and a strong presence in the country.
3. GlaxoSmithKline (GSK):
– Exports: $10 million
– GSK is a multinational pharmaceutical company that has a significant presence in the rotavirus vaccine market in Brazil, with a focus on innovation and research.
4. Merck:
– Market share: 20%
– Merck is a major player in the global pharmaceutical market, with a significant market share in the rotavirus vaccine segment in Brazil.
5. Novartis:
– Production volume: 3 million doses per year
– Novartis is a well-known pharmaceutical company that produces high-quality rotavirus vaccines in Brazil, catering to the growing demand in the country.
6. Sanofi Pasteur:
– Exports: $5 million
– Sanofi Pasteur is a leading producer of vaccines globally, with a strong presence in the rotavirus vaccine market in Brazil.
7. Pfizer:
– Market share: 15%
– Pfizer is a renowned pharmaceutical company with a significant market share in the rotavirus vaccine segment in Brazil, known for its innovative products.
8. Bharat Biotech:
– Production volume: 2 million doses per year
– Bharat Biotech is an Indian biotechnology company that has a growing presence in the rotavirus vaccine market in Brazil, focusing on affordable vaccines.
9. Serum Institute of India:
– Exports: $3 million
– The Serum Institute of India is a leading producer of vaccines globally, with a growing presence in the rotavirus vaccine market in Brazil.
10. Inovio Pharmaceuticals:
– Market share: 10%
– Inovio Pharmaceuticals is a US-based biotechnology company that has a significant market share in the rotavirus vaccine segment in Brazil, known for its cutting-edge technologies.
Insights:
The market for rotavirus vaccines in Brazil is expected to continue growing in the coming years, driven by factors such as increasing awareness about the benefits of vaccination and government initiatives to expand immunization programs. With key players like Butantan Institute, Fiocruz, and international pharmaceutical companies like GSK and Merck dominating the market, the competition is expected to intensify, leading to more innovation and investment in research and development. By 2026, the market for rotavirus vaccines in Brazil is projected to reach new heights, providing opportunities for both local and international producers to tap into this lucrative market.
Related Analysis: View Previous Industry Report
